FDA Approvals in Oncology: July-September 2025
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
Tag: Bladder cancer
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...